Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C20H16N4O and a molecular weight of approximately 328.4 g/mol. It is listed in chemical databases such as PubChem (CID:1504) and ZINC15 as a pharmaceutical or research compound[1]. The structure features a benzimidazole core substituted with a biphenylyl group and an amidine moiety. There is no evidence that this molecule has been approved for clinical use or advanced to late-stage drug development; it appears primarily in chemical libraries for screening purposes. Its mechanism of action and biological targets are not described in available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-(2-hydroxy-(1,1'-biphenyl)-3-yl)-1H-1,3-benzodiazole-5-carboximidamide.